CEREVEL THERAPEUTICS HLDNG I's ticker is and the CUSIP is 15678U908. A total of 5 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,821,410 | -7.0% | 69,000 | -3.9% | 0.01% | -8.3% |
| Q1 2024 | $3,034,986 | -42.4% | 71,800 | -42.2% | 0.01% | -14.3% |
| Q4 2023 | $5,270,320 | +32.7% | 124,300 | -31.7% | 0.01% | +7.7% |
| Q3 2023 | $3,973,060 | +10.3% | 182,000 | +60.6% | 0.01% | +8.3% |
| Q2 2023 | $3,601,807 | +303.5% | 113,300 | +209.6% | 0.01% | +300.0% |
| Q1 2023 | $892,674 | -69.6% | 36,600 | -60.6% | 0.00% | -57.1% |
| Q4 2022 | $2,933,220 | +244.7% | 93,000 | +209.0% | 0.01% | +250.0% |
| Q3 2022 | $851,000 | +977.2% | 30,100 | +903.3% | 0.00% | – |
| Q2 2022 | $79,000 | -80.7% | 3,000 | -74.4% | 0.00% | – |
| Q1 2022 | $410,000 | -85.8% | 11,700 | -86.8% | 0.00% | -100.0% |
| Q4 2021 | $2,879,000 | -14.2% | 88,800 | -22.0% | 0.00% | -50.0% |
| Q3 2021 | $3,357,000 | – | 113,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 243,400 | $6,435,000 | 0.37% |
| SIMPLEX TRADING, LLC | 4,200 | $111,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 8,800 | $233,000 | 0.00% |
| GROUP ONE TRADING LLC | 3,000 | $79,000 | 0.00% |